202 related articles for article (PubMed ID: 7399743)
1. Cytotoxicity in vitro of blood lymphocytes from bladder cancer patients and controls to allogeneic or autologous tumor cells derived from established cell lines or short-term cultures.
Troye M; Vilien M; Pape GR; Perlmann P
Int J Cancer; 1980 Jan; 25(1):33-43. PubMed ID: 7399743
[TBL] [Abstract][Full Text] [Related]
2. Lymphocyte-mediated lysis of tumor cells in vitro (ADCC), induced by serum antibodies from patients with urinary bladder carcinoma or from controls.
Troye M; Hansson Y; Paulie S; Perlmann P; Blomgren H; Johansson B
Int J Cancer; 1980 Jan; 25(1):45-51. PubMed ID: 7399744
[TBL] [Abstract][Full Text] [Related]
3. Humoral and cellular immune reactions against tumor cells in patients with urinary bladder carcinoma. Correlation between direct and antibody-dependent cell-mediated cytotoxicity.
Hansson Y; Paulie S; Larsson A; Lundblad ML; Perlmann P; Näslund I
Cancer Immunol Immunother; 1983; 16(1):23-9. PubMed ID: 6556949
[TBL] [Abstract][Full Text] [Related]
4. Human spontaneous lymphocyte-mediated cytotoxicity (SLMC) against malignant and normal tissue-derived target cell lines tested in autologous and allogeneic combinations by the microcytotoxicity assay.
Vilien M; Troye-Blomberg M; Perlmann P; Wolf H; Rasmussen F
Cancer Immunol Immunother; 1983; 14(3):137-44. PubMed ID: 6573229
[TBL] [Abstract][Full Text] [Related]
5. Membrane-associated antigens on tumor cells from transitional-cell carcinoma of the human urinary bladder. I. Immunological characterization by xenogeneic antisera.
Schneider MU; Troye M; Paulie S; Perlmann P
Int J Cancer; 1980 Aug; 26(2):185-92. PubMed ID: 7203712
[TBL] [Abstract][Full Text] [Related]
6. Cellular cytotoxicity in transitional cell carcinoma of the human urinary bladder - a summary.
Perlmann P; Troye M; Pape G; Blomgren H; Johansson B
Urol Res; 1978; 6(4):207-9. PubMed ID: 741533
[TBL] [Abstract][Full Text] [Related]
7. Disease-related lymphocyte cytotoxicity in rats bearing transitional cell carcinoma of bladder. Effect of immunomodulators.
Moroz C; Madgar I; Twig S; Lindner A; Many M
Int J Cancer; 1982 Jun; 29(6):667-72. PubMed ID: 6980847
[TBL] [Abstract][Full Text] [Related]
8. Interferon-alpha-2b enhances the natural killer activity of patients with transitional cell carcinoma of the bladder.
Carballido JA; Moltó LM; Manzano L; Olivier C; Salmerón OJ; Alvarez de Mon M
Cancer; 1993 Sep; 72(5):1743-8. PubMed ID: 8348503
[TBL] [Abstract][Full Text] [Related]
9. MHC nonrestricted cytotoxic T cell clones with selective specificity from patients with transitional cell carcinoma (TCC) of the urinary bladder.
Hansson Y; Vargas-Cortes M; Paulie S; Perlmann P
Cancer Immunol Immunother; 1988; 27(3):205-12. PubMed ID: 3263206
[TBL] [Abstract][Full Text] [Related]
10. Cellular and humoral in vitro cytotoxicity against autologous bladder tumor cells in humans. Differences in autologous cytotoxicity against non-invasive and invasive transitional-cell tumors of the urinary bladder.
Jacobsen F
Acta Pathol Microbiol Scand C; 1981 Aug; 89(4):235-9. PubMed ID: 7315359
[TBL] [Abstract][Full Text] [Related]
11. Production of antibodies to cellular antigens by EBV-transformed lymphocytes from patients with urinary bladder carcinoma.
Paulie S; Lundblad ML; Hansson Y; Koho H; Ben-Aissa H; Perlmann P
Scand J Immunol; 1984 Nov; 20(5):461-70. PubMed ID: 6095441
[TBL] [Abstract][Full Text] [Related]
12. Transitional cell carcinoma: lymphocyte-mediated cytotoxicity.
Troye M; Pape GR
Natl Cancer Inst Monogr; 1978 Dec; (49):85-7. PubMed ID: 311895
[TBL] [Abstract][Full Text] [Related]
13. A 51chromium isotope release assay for detecting cytotoxicity to human bladder carcinoma.
O'Toole C
Int J Cancer; 1977 Mar; 19(3):324-31. PubMed ID: 844912
[TBL] [Abstract][Full Text] [Related]
14. HLA antigen expression on urothelial cells: detection by antibody-dependent cell-mediated cytotoxicity.
O'Toole CM; Tiptaft RC; Stevens A
Int J Cancer; 1982 Apr; 29(4):391-5. PubMed ID: 7085129
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of soluble Fas in the serum of patients with bladder cancer.
Mizutani Y; Yoshida O; Bonavida B
J Urol; 1998 Aug; 160(2):571-6. PubMed ID: 9679930
[TBL] [Abstract][Full Text] [Related]
16. The requirement for monocytes in spontaneous cytotoxicity by lymphocytes from healthy donors and melanoma patients.
de Vries JE; Mendelsohn J; Bont WS
Int J Cancer; 1980 Jan; 25(1):73-84. PubMed ID: 7399746
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of circulating cytotoxic lymphocytes against autologous tumors in patients with bladder cancer.
Mizutani Y; Okada Y; Terachi T; Yoshida O
J Urol; 1996 Mar; 155(3):888-92; discussion 892-4. PubMed ID: 8583600
[TBL] [Abstract][Full Text] [Related]
18. Activation by the protein-bound polysaccharide PSK (krestin) of cytotoxic lymphocytes that act on fresh autologous tumor cells and T24 human urinary bladder transitional carcinoma cell line in patients with urinary bladder cancer.
Mizutani Y; Yoshida O
J Urol; 1991 May; 145(5):1082-7. PubMed ID: 2016797
[TBL] [Abstract][Full Text] [Related]
19. Significance of cytotoxic activity of peripheral blood lymphocytes against autologous tumor cells in patients with bladder cancer.
Mizutani Y; Okada Y; Yoshida O; Bonavida B
Cancer Biother Radiopharm; 1996 Dec; 11(6):385-91. PubMed ID: 10851499
[TBL] [Abstract][Full Text] [Related]
20. Lymphocyte cytotoxicity against autologous bladder tumor cells in humans, investigated by use of a chromium-51 release assay.
Jacobsen F
Acta Pathol Microbiol Scand C; 1981 Jun; 89(3):175-80. PubMed ID: 7315355
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
